Travere Therapeutics grew its share prices by 40.78 percent week-on-week, as investors increased their positions after ...
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best low priced biotech stocks to invest in. Ocular Therapeutix Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results